STOCK TITAN

Vanguard disaggregates holdings; AtriCure (NASDAQ: ATRC) shows 0 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

AtriCure Inc Schedule 13G/A Amendment No. 6: The Vanguard Group reports beneficial ownership of 0 shares of Common Stock, representing 0%. The filing notes an internal realignment on January 12, 2026 that disaggregated reporting by Vanguard subsidiaries. The amendment is signed by Ashley Grim on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Amendment clarifies Vanguard's disaggregated reporting; no beneficial stake reported.

The filing explicitly states 0 shares beneficially owned and 0% of the class, reflecting the post‑realignment reporting structure described in SEC Release No. 34-39538.

Timing and cash‑flow treatment are not relevant here; subsequent filings by Vanguard subsidiaries may show any holdings separately.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

Does The Vanguard Group own AtriCure (ATRC) shares after this amendment?

No, The Vanguard Group reports 0 shares beneficially owned, representing 0% of the class. The filing attributes prior holdings to disaggregated subsidiaries after an internal realignment on January 12, 2026.

What does the January 12, 2026 realignment mean in the 13G/A?

It means certain Vanguard subsidiaries now report holdings separately, per SEC Release No. 34-39538. The filing states subsidiaries pursue the same strategies and Vanguard no longer is deemed to beneficially own those subsidiary holdings.

Who signed the Schedule 13G/A amendment for ATRC?

The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/26/2026. The signature certifies the disclosure about beneficial ownership and internal realignment.

Will separate Vanguard entities file their own disclosures for ATRC?

Yes, the amendment indicates subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538. Individual subsidiary filings may show holdings going forward.
Atricure

NASDAQ:ATRC

View ATRC Stock Overview

ATRC Rankings

ATRC Latest News

ATRC Latest SEC Filings

ATRC Stock Data

1.50B
47.79M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MASON